A detailed history of Qube Research & Technologies LTD transactions in Brainsway Ltd. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 10,846 shares of BWAY stock, worth $171,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,846
Previous 15,952 32.01%
Holding current value
$171,909
Previous $209,000 22.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$11.47 - $16.71 $58,565 - $85,321
-5,106 Reduced 32.01%
10,846 $161,000
Q2 2025

Aug 14, 2025

SELL
$7.86 - $13.15 $24,185 - $40,462
-3,077 Reduced 16.17%
15,952 $209,000
Q1 2025

May 15, 2025

BUY
$9.19 - $11.41 $174,876 - $217,120
19,029 New
19,029 $180,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $262M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.